Início › Câncer Endometrial › Michigan

Ensaios clínicos de Câncer Endometrial em Michigan

43 estudos para Câncer Endometrial estão buscando participantes em locais em Michigan.

Cidades em Michigan

Texto oficial do estudo (Inglês)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
University of Michigan Rogel Cancer Center, Ann Arbor
Bronson Battle Creek, Battle Creek
e mais 37

RecrutandoFase 2

Todas as idades · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05564377

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

South Texas Accelerated Research Therapeutics (START), Grand Rapids

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06270706

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

University of Michigan Rogel Cancer Center, Ann Arbor
Bronson Battle Creek, Battle Creek
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
e mais 25

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 2 de out. de 2026 · NCT07198074

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Profound Research -OMG - TriAtria Cancer Center, Farmington Hills

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06760819

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

BAMF Health, Grand Rapids

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07189871

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Henry Ford Health, Detroit
Valley OB-GYN Clinic, Saginaw

RecrutandoEstudo observacional

Idades 18 e acima · Mulheres · Atualizado em 29 de set. de 2026 · NCT05051722

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Bronson Battle Creek, Battle Creek
Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Bronson Methodist Hospital, Kalamazoo
e mais 7

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 28 de set. de 2026 · NCT05112601

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Karmanos Cancer Institute, Detroit

RecrutandoFase 1/2

Idades 18 e acima · Mulheres · Atualizado em 24 de set. de 2026 · NCT04590326

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, Grand Rapids

RecrutandoFase 2

Idades de 18 a 130 · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT05489211

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

START Midwest, Grand Rapids

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Barbara Ann Karmanos Cancer Institute, Detroit
BAMF Health Inc., Grand Rapids

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07114601

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

GSK Investigational Site, Detroit

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07213609

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Cancer & Hematology Centers of Western Michigan, Grand Rapids

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Karmanos Cancer Institiute, Detroit

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT06293898

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Corewell Health, Grand Rapids

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 9 de set. de 2026 · NCT07166094

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06400472

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Research Site, Ann Arbor

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 3 de set. de 2026 · NCT06989112

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Karmanos Cancer Institute, Detroit

RecrutandoFase 1

Idades 15 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

C S Mott Children's Hospital, Ann Arbor

RecrutandoFase 1/2

12 Months – 30 Years · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04851119

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Research Site, Detroit

RecrutandoFase 1/2

Idades de 18 a 130 · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT05797168

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Karmanos Cancer Institute, Detroit

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 21 de ago. de 2026 · NCT05548296

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Karmanos Cancer Center, Detroit

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07470853

A Study of PHST001 in Advanced Solid Tumors

University of Michigan Rogel Cancer Center, Ann Arbor
START Center for Cancer Research - Midwest, Grand Rapids

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT06840886

A Study of MGC026 in Participants With Advanced Solid Tumors

START Midwest, Grand Rapids

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT06242470

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Karmanos Cancer Institute, Detroit

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT05592626

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

START - Midwest, Grand Rapids

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT07444814

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Karmanos Cancer Institute, Detroit
START Midwest, Grand Rapids

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 4 de ago. de 2026 · NCT05579366

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Research Site, Ann Arbor
Research Site, Ann Arbor

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 29 de jul. de 2026 · NCT07044336

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Investigative Site #120, Detroit

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 23 de jul. de 2026 · NCT06974110

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Karmanos Cancer Institute, Detroit
Karmanos Cancer Institute, Farmington Hills

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT05208762

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

START Midwest, Grand Rapids

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 7 de jul. de 2026 · NCT05768139

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Henry Ford Health Hospital, Detroit

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT05377996

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Karmanos Cancer Institute, Detroit

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de jun. de 2026 · NCT07503808

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

START Midwest, Grand Rapids

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 2 de jun. de 2026 · NCT06730347

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Henry Ford Cancer Institute, Detroit

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 17 de dez. de 2025 · NCT05856981

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

START Midwest, Grand Rapids

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 11 de dez. de 2025 · NCT06943521

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

University of Michigan, Ann Arbor

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 4 de nov. de 2025 · NCT05902988

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

Barbara Ann Karmanos Cancer Hospital, Detroit

RecrutandoFase 2

Idades de 18 a 70 · Mulheres · Atualizado em 30 de out. de 2025 · NCT06481592

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Ann Arbor
Massive Bio SYNERGY-AI site, Lansing

RecrutandoEstudo observacional

Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

University of Michigan, Ann Arbor

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2025 · NCT05941507

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.